Stage III Prostate Cancer
Oncology
Prevalence
256.0 / 100K
Incidence
111.0 / 100K/yr
0 drugs in development·0 companies·3 clinical trials
Frequently asked questions
How many clinical trials target Stage III Prostate Cancer?
There are 3 clinical trials targeting Stage III Prostate Cancer tracked by BioSniper.
What is the prevalence of Stage III Prostate Cancer?
The estimated prevalence of Stage III Prostate Cancer is approximately 256.0 per 100,000 population.
Deep-dive into Stage III Prostate Cancer
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis